Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

NEW YORK – OpGen announced on Monday that it has received regulatory approval from the Chinese National Medical Products Administration for its Curetis Unyvero system as an in vitro diagnostics instrument system. 

The submission was filed in February 2019 and included the Unyvero A50 Analyzer, the Unyvero L4 Lysator, and the Unyvero C8 Cockpit. OpGen said in a statement that the NMPA has been "actively engaged" in the review process for the system with its subsidiary Curetis and its Chinese partner Beijing Clear Biotech.

The Unyvero A50 pneumonia cartridge is still under review by the NMPA and if cleared will be the first Unyvero-based diagnostic application for the Chinese market, OpGen said in a statement. The cartridge was also submitted to regulators in February 2019, and timelines for NMPA submissions have been affected by the SARS-CoV-2 pandemic, OpGen said. Commercial launch of the Unyvero platform in China is subject to approval of the pneumonia cartridge, it added.

Curetis and Beijing Clear Biotech have an exclusive multi-year distribution agreement for the Unyvero platform and cartridges in China. Under the agreement, after NMPA approval Beijing Clear will purchase a minimum of 360 Unyvero systems and more than 1.5 million cartridges total over an eight-year exclusivity period. Expected revenue for OpGen as a result of the agreement is approximately $180 million. 

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.